BackPAVmed- Warrants (29/01/2022) Overview

PAVmed- Warrants (29/01/2022) Minority Interest

Track PAVmed- Warrants (29/01/2022)'s minority interest ($-16M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$-15.74M
↓ 99.83% YoYΔ $9.36B vs prior year quarter

Peer trimmed avg / median

Loading

PAVmed- Warrants (29/01/2022) Minority Interest History

Loading

PAVmed- Warrants (29/01/2022) vs. peers: Minority Interest Comparison

Loading

PAVmed- Warrants (29/01/2022) Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PAVmed- Warrants (29/01/2022) (PAVMW) FAQ

As of the most recent data (June 2026), PAVMW shows a minority interest of $-16M. That compares with $-9.4B in the prior-year period — up 99.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PAVMW's minority interest is now $-16M (was $-9.4B) — a 99.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether PAVmed- Warrants (29/01/2022) is outperforming or lagging.

Tracking PAVMW's minority interest over time shows whether PAVmed- Warrants (29/01/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $-16M That compares with $-9.4B in the prior-year period — up 99.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has PAVmed- Warrants (29/01/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $-16M) with ownership activity and broader fundamentals.

PAVmed- Warrants (29/01/2022)'s minority interest is $-16M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.